Now we have 5 finished products (urogynecology).
Now we need funding for:
- Completion of R&D of the original (non-genetic) medicine, 5 release forms (injections, suppositories, pessaries, gel, spray)
- Registration of a new medicine, including abroad
- Organization of the representative office
- Launch and advertising
The approximate period of pre-launch is 2 years, the break-even point is 1 year, next comes the return on investment .